Consort Medical Share Price (CSRT)

Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Consort Medical Plc LSE:CSRT London Ordinary Share GB0000946276 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 1,010.00 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
1,005.00 1,010.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 305.10 12.50 21.30 47.4 502
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 1,010.00 GBX
Related Shares
Smith & Nephew (SN.), Convatec (CTEC), Salvarx (SALV), Sensyne Health (SENS)

Consort Medical (CSRT) Latest News

Real-Time news about Consort Medical Plc (London Stock Exchange): 0 recent articles
More Consort Medical News
Consort Medical Investors    Consort Medical Takeover Rumours

Consort Medical (CSRT) Discussions and Chat

Consort Medical Forums and Chat

Date Time Title Posts
11/8/202011:05Consort Medical - Medical Devices148
17/11/201414:19Aesica acquisition bolsters growth prospects-

Add a New Thread

Consort Medical (CSRT) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Consort Medical trades in real-time

Consort Medical (CSRT) Top Chat Posts

DateSubject
29/6/2022
09:20		Consort Medical Daily Update: Consort Medical Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker CSRT. The last closing price for Consort Medical was 1,010p.
Consort Medical Plc has a 4 week average price of 0p and a 12 week average price of 0p.
The 1 year high share price is 0p while the 1 year low share price is currently 0p.
There are currently 49,733,065 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Consort Medical Plc is £502,303,956.50.
Read Full Thread
Reply
02/12/2019
14:34		rmillaree: Perhaps i am the one to switch off the lights with regard to this share ?- i have held on for what i was hoping would be long enough for any counter bid to turn up. In the absence of any headway in that regard i have sold up today. Best not being too greedy - and being honest by holding on i have been slightly greedy in that regard anyway.
Read Full Thread
Follow
Reply
18/11/2019
22:22		cerrito: I had some issues with my RNS feed so have just caught up with this and indeed I see that CSRT did not themselves issue a RNS this morning. As per my previous posts no surprise at all that this is subject to an offer, although I had been thinking in terms of private equity. Yes this is a rare enough type of company in an interesting niche that there is a chance of another offer so no real surprise that the current share price is higher than the offer price. Like many people here I am finding that almost a full time job to find homes for stock holdings being taken over-last week it was AMER.
Read Full Thread
Follow
Reply
18/11/2019
13:59		dexdringle: Well pap, it looks like its just you and me ! I bought these at £7.88 a few weeks ago but didn't expect a takeover. Sold today at £10.40. Assume the premium to the takeover price of £10.10 is because a counter bid might happen - but this time am happy to take my profit and walk away ! Good luck to anyone continuing to hold in the hope of a counter bid. And sorry for anyone for whom the takeover is at a lower price than they are owed (I've been there too - see Inmarsat)
Read Full Thread
Follow
Reply
14/9/2019
21:30		cerrito: I made it to the AGM. Voter turn out 42m of the 49m shares being voted, which to me is high, although as I normally track it for AIM companies maybe par for the course for a fully listed one. The remuneration report had 5m odd abstentions, 5m odd against ; the rest of the resolutions passed in the high 90's Asked about the fire and the AGM statement. The reason the figure has gone up from the £3m/£5m hit to profit in the July 15 RNS to £7m/£9m in the AGM statement is that the original figure was very preliminary as they had to get an announcement out. Note that they have not uncovered the root cause and the insurance assessors have not been able to get on site. Initially the whole plant was closed as the H&S people took over but now only the effected part is closed. They recognized that it took longer than originally anticipated to do the clear up. Also currently anticipated that whole plant will be fully up and running in the second half of the financial year. Fortunate that no personal injuries Too bad that no one asked what impact this has had on their reputation as a reliable supplier and to what extent Aiseca can make up from their other sites this shortfall at Cramlington, Queenborough is in process of being shut down which will be done by financial year end. Discussion on consolidation of other sites . A question asked about the two German operations - Zwickau near Dresden which produces and Mannheim which packages and no change anticipated in this arrangement. In terms of a hard Brexit two big issues. The first is if the EU will prohibit a UK entity from being a QP- a Qualified Person. If they do, this can handle through their German and Italian operations and applies to Aiseca and not BPK. Ie this would be a pain but surmountable, The second is getting raw materials and they had a dress rehearsal of this in March. As per scrip data, which is not completely reliable, sales of Mylan going well. Very clear that no chance of share buybacks given debt and capex levels. Stated that are not being too energetic in Cambridge and do not see that they will need to go into reverse as they did 16 years ago with their R&D centre. Pointed out that ramping up has been gradual and they are earning revenue. I have to say that we do seem to be flying rather blind and rather spooky that they have not uncovered the root cause. Operating profit this FY will be half of that in the previous year and one can only assume there will be an impact in the next financial year. I have trimmed and would have sold out completely if I did not think that they are an acquisition candidate.
Read Full Thread
Follow
Reply
21/8/2019
10:38		cerrito: Thanks for that BigBloke. As you say share price performance very disappointing and the current price the same as at May 18th 2007 when I made my first purchase at 749.77. I do not see the Chairman instigating a shake up of Management nor indeed do I see major shareholders like Invesco, Polar and Schroders agitating for change; as he has been in post since April if he was going to do it I feel he would have done it by now…although it is possible but to my mind very unlikely that the fire showed up very serious management failings.Just a gut feeling and I may be wrong and indeed will be interesting to see the voting figures at the AGM. All the strategic decisions you highlight would have been signed off by the Board and they are not blameless. Indeed I have just caught up with Carlo whose shares have been suspended because they cannot produce financials due to problems in their automotive division which makes one wonder why the CSRT ever got it into their head to make a tentative bid to buy the whole company; I did not give it much attention at the time as I had so few shares but very spooky-albeit that there has been a subsequent change of Chairman. You mention the sale of King=and of course they want to get back into the US;that said the reasons for the sale they gave at the time seemed logical to me. As per my 132 I see CSRT as a good target for private equity. As a matter of interest when did they can their R&D activities the previous time?
Read Full Thread
Follow
Reply
17/8/2019
00:51		bigbloke: Not sure how much longer the current management teams at Consort and Bespak may have left before the new Chairman is forced to make some sweeping changes. The current fall in share price is returning the company to levels not seen in over a decade. Its growth of the Cambridge based innovation centre, whilst having produced some tangible results, is beginning to feel like the organisation of old - pre name change to Consort, when the previous R&D function was en masse removed due to it being overblown and costly. Jon Glenn's turnaround strategy seems to be failing. Purchasing of Aesica and divestment of King Systems has not made much of an impression. The total organisation is bigger, but the net value is now smaller than that seen in a long while. Very concerned that a take over is not far away...
Read Full Thread
Follow
Reply
18/7/2019
11:32		kron76: Tempted but wondering if more news re the incident and cost impact might be prudent. Got out mid 900s a few weeks ago in a pure bit of luck as had a half decent profit and wanted the cash to use elsewhere - back just above original purchase price so certainly been thinking of coming back in.
Read Full Thread
Follow
Reply
17/7/2019
22:08		cerrito: I was interested to see if they mentioned the kind of incident they have had in their key risks section in the Annual Report; that for this year is net yet out but I see in the 17/18 AR on page 27 they do flag up this risk. I also see on June 13 2018 Polar had 5.04% shareholding ; I flag this up because today's RNS suggests that Polar went from zero to 7% which does not seem to be the case as I could not see that Polar had sold down since June 2018. I have enough of these but for those with little or no holdings you may want to take a look at today's price of about 770.
Read Full Thread
Follow
Reply
13/6/2019
17:13		cerrito: Have to look at the results in detail but the share price reaction seems about right. I see that RBC has an as of today an outperform at 1130p
Read Full Thread
Follow
Reply
02/5/2019
23:21		cerrito: Thanks Typo56 for unearthing that in your 124. If the market felt something was cooking, I suspect that the price would be higher. I have to confess I have never heard of the German company Given the current FX rate and share price, as well as what it is up to and it's shareholder base, it would not surprise me at all if there was an offer but such a possibility plays little part in my decision to maintain my holding in the company.
Read Full Thread
Follow
Reply
Consort Medical share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
CSRT
Consort Me..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220630 06:23:51